Dolastatin-15 derivatives in combination with taxanes

Details Dolastatin-15 derivatives in combination with taxanes Dolastatin-15 derivatives in combination with taxanes

1997-03-13

2000-08-15

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 17, 514 16, 514449, A61K 3800, A61K 31335

Patent

active

061036986

ABSTRACT:
The present invention provides compositions and methods for the treatment of cancer in a subject wherein compounds of Formula I as defined herein in combination with paclitaxel, taxotere or modified taxane or taxoid analogs provide enhanced anticancer effects over the effects achieved with the individual compounds.

REFERENCES:
patent: 4816444 (1989-03-01), Pettit et al.
patent: 4879278 (1989-11-01), Pettit et al.
patent: 5227400 (1993-07-01), Holton et al.
patent: 5248796 (1993-09-01), Chen et al.
patent: 5250683 (1993-10-01), Holton et al.
patent: 5254580 (1993-10-01), Chen et al.
patent: 5272171 (1993-12-01), Ueda et al.
patent: 5278324 (1994-01-01), Kingston et al.
patent: 5447936 (1995-09-01), Hausheer et al.
patent: 5484612 (1996-01-01), Brown
patent: 5494930 (1996-02-01), Shimizu et al.
patent: 5502032 (1996-03-01), Haupt et al.
patent: 5504191 (1996-04-01), Pettit et al.
patent: 5525613 (1996-06-01), Wynn et al.
patent: 5530097 (1996-06-01), Pettit et al.
patent: 5543423 (1996-08-01), Zelle et al.
patent: 5565478 (1996-10-01), Kohn et al.
Conlon, D. et al., "In vivo antitumor activity of LU103793 in combination with Taxol," J. of Cancer Research, 38:320 (Mar. 21, 1997). (From Proceedings of the American Association for Cancer Research Annual Meeting, 1997, Abstract No. 2142).
Leopold, W. et al., "Therapeutic Synergy of Trimetrexate (C1-898) in Combination With Doxorubicin, Vincristine, Cytoxan, 6-Thioguanine, Cisplatin, or 5-Fluorouracil Against Intraperitoneally Implanted P388 Leukemia," NCI Monographs, (5): 99-104 (1987).
Schabel, Jr., F.M. et al., "Quantitative Evaluation of Anticancer Agent Activity in Experimental Animals," Pharmac Ther. A., 1: 411-435 (1977).
Chou, T.-C. et al., "Computerized Quantitation of Synergism and Antagonism of Taxol, Topotecan, and Cisplatin Against Human Teratocarcinoma Cell Growth" a Rational Approach to Clinical Protocol Design, J. of the National Cancer Institute, 86 (20): 1517-1524 (1994).
Knick, V.C. et al., "Vinorelbine Tartrate and Paclitaxel Combinations: Enhanced Activity Against In Vivo P388 Murine Leukemia Cells," J. of the National Cancer Institute, 87 (14): 1072-1077 (1995).
Bissery, M.C. et al., "Docetaxel in combination with vinorelbine: Preclinical-clinical correlation," Proc. Am. Soc. Clin. Oncol. 15 32 Meet, 487 (1996) Abstract 96-43670.
Beckwith, M. et al., "Growth Inhibition of Human Lymphoma Cell Lines by the Marine Products, Dolastatins 10 and 15," J. Nat'l. Cancer Inst., 85: 483-488 (1993).
Freidinger, R. et al., "Protected Lactam-Bridged Dipeptides for Use as Conformational Constraints in Peptides," J. Org. Chem.: 104-109 (1982).
Galeotti, N. et al., "Formation of Oxazolines and Thiazolines in Peptides by the Mitsunobu Reaction," Tetrahedron Letters, 33(20): 2807-2810 (1992).
Wipf, P. et al., "A Short, Stereospecific Synthesis of Dihydrooxazoles from Serine and Threonine Derivatives," Tetrahedron Letters, pp. 907-910 (1992).
Tully, W. R. et al., "2-(Oxadiazolyl)- and 2-(Thiazolyl)imidazo[1,2-a]pyrimidines as Agonists and Inverse Agonists at Benzodiazepine Receptors," J. Med. Chem., 34: 2060-2067 (1991).
Miyazaki, K. et al., "Synthesis and Antitumor Activity of Novel Dolastatin-10 Analogs," Chem. Pharm. Bull., 43(10): 1706-1718 (1995).
Pettit, G. R. et al., "The Isolation and Structure of a Remarkable Marine Animal Antineoplastic Constituent: Dolastatin 10", J. Am. Chem. Soc., 109: 6883-6885 (1987).
Pettit, G. R. et al., "Antineoplastic Agents 337. Synthesis of Dolastatin-10 Structural Modifications," Anti-Cancer Drug Design, 10: 529-544 (1995).
Pettit, G. R et al., "Antineoplastic Agents. 220. Synthesis of Natural (-)-Dolastatin 15", J. Am. Chem. Soc., 113: 6692-6693 (1991).
Bai, R. et al., "Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia. Interaction with tubulin and effects on cellular microtubules", 1-Pharmacology, Abstract 117:103735g p. 41 (1992).
Pettit, G. R. et al., "Isolation and Structure of the Cytostatic Depsipeptide Dolastatin 13 from the Sea Hare Dolabella auricularia," J. Am. Chem. Soc., 111 (13): 5015-5017 (1989).
Schmidt, U. et al., "Amino Acids and Peptides; 59. Synthesis of Biologically Active Cyclopeptides; 9. Synthesis of 16 Isomers of Dolastatin 3; I. Synthesis of the 2-(1-aminoalkyl)-thiazole-4-carboxylic Acids", Synthesis: 233-236 (Mar. 1987).
Pettit, G. R. et al., "Isolation and Structure of the Cytostatic Linear Depsipeptide Dolastatin 15", J. Org. Chem., 54: 6005-6006 (1989).
Rose, W.C., "Taxol-Based Combination Chemotherapy and Other In Vivo Preclinical Antitumor Studies", J. of the National Cancer Institute Monographs (15): 47-53 (1993).
Holton, R. A. et al., "First Total Synthesis of Taxol. 1. Functionalization of the B Ring," J. Am. Chem. Soc., 116: 1597-1601 (1994).
Nicolaou, K. C. et al., "Total Synthesis of Taxol," Nature, 367: 630-634 (1994).
Kumar, N., "Taxol-induced Polymerization of Purified Tubulin," J. Biol. Chem. 256: 10435-10441 (1981).
Rowinsky, E. K. et al., "Taxol: A Novel Investigational Antimicrotubule Agent," J. Nat'l Cancer Inst., 82: 1247-1259 (1990).
Schiff, P. B. et al., "Promotion of Microtubule Assembly in vitro by taxol," Nature, 277: 665-667 (1979).
McGuire, W. P. et al., "Taxol: A Unique Antineoplastic Agent with Significant Activity in Advanced Ovarian Epithelial Neoplasms," Ann. Int. Med., 111: 273-279 (1989).
Holmes, F. et al., "Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer," J. Nat'l Cancer Inst., 83: 1797-1805 (1991).
Kohn, E. et al., "A Pilot Study of Taxol, Cisplatin, Cyclophosphamide, and G-CSF In Newly Diagnosed Stage III/IV Ovarian Cancer Patients," Am. Society for Clinical Oncology, 12: Abstract 814 (1993).
Bai, R. et al., "Structure-Activity Studies with Chiral Isomers and with Segments of the Antimitotic Marine Peptide Dolastatin 10," Biochem. Pharmacology, 40: 1859-1864 (1990).
Kohn, E. C. et al., "Dose-Intense Taxol: High Response Rate in Patients With Platinum-Resistant Recurrent Ovarian Cancer," J. Nat'l Cancer Inst., 86:18-24 (1994). Abstract *814.

Affiliated with

Also associated with

Rating

Dolastatin-15 derivatives in combination with taxanes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dolastatin-15 derivatives in combination with taxanes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dolastatin-15 derivatives in combination with taxanes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2006915